{"Abbreviation":["3-MeO-PCE"],"Aliases":["3-Methoxy-pce","3-Meo-pce","3-Methoxy eticyclidine","Cyclohexanamine, N-ethyl-1-(3-methoxyphenyl)-","N-Ethyl-1-(3-methoxyphenyl)cyclohexanamine","RefChem:163297","2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexane"],"CAS":"1364933-80-1","ChemicalClasses":["arylcyclohexylamine"],"Chirality":"achiral","Esters":[],"Formating":[],"HeavyAtomCount":17,"IUPACName":"N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine","InChI":"InChI=1S/C15H23NO/c1-3-16-15(10-5-4-6-11-15)13-8-7-9-14(12-13)17-2/h7-9,12,16H,3-6,10-11H2,1-2H3","InChIKey":"OFGOOZLOGUNDFS-UHFFFAOYSA-N","MolecularFormula":"C\u003csub\u003e15\u003c/sub\u003eH\u003csub\u003e23\u003c/sub\u003eNO","MolecularWeight":"233.35 g/mol","PD":"PD057144","PubChemId":57461569,"Record Description":["Wikipedia|List of designer drugs|Dissociatives|Arylcyclohexylamines","3-Methoxyeticyclidine (3-MeO-PCE) is a dissociative anesthetic drug that has been sold online as a designer drug.[1] The activity of 3-MeO-PCE in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle wrote that 3-MeO-PCE was qualitatively similar to PCP. 3-MeO-PCE has a Ki of 61 nM for the NMDA receptor, 115 nM for the serotonin transporter, 4519 nM for the sigma1 receptor and 525 nM for the sigma2 receptor."],"RefCount":3,"RefCur":"","References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/3-MeO-PCE","Name":"3-Methoxyeticyclidine","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q20707021","Name":"3-Methoxyeticyclidine","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/57461569","Name":"3-Methoxyeticyclidine","Sub":false}]},{"Name":"Probes \u0026 Drugs","Urls":[{"Link":"https://www.probes-drugs.org/compound/PD057144","Name":"3-Methoxyeticyclidine","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=1364933-80-1","Name":"3-Methoxyeticyclidine","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/PX6CYK9I4H","Name":"3-Methoxyeticyclidine","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID701032419","Name":"3-Methoxyeticyclidine","Sub":false}]}],"Refs":["National Center for Biotechnology Information. PubChem Compound Summary for CID 57461569, 3-Methoxyeticyclidine. Accessed September 6, 2025. \u003ca href=https://pubchem.ncbi.nlm.nih.gov/compound/57461569\u003ehttps://pubchem.ncbi.nlm.nih.gov/compound/57461569\u003c/a\u003e","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 3-Methoxyeticyclidine. UNII: PX6CYK9I4H. Global Substance Registration System. Accessed September 6, 2025. \u003ca href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PX6CYK9I4H\u003ehttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/PX6CYK9I4H\u003c/a\u003e"],"SMILES":"CCNC1(CCCCC1)C2=CC(=CC=C2)OC","SaltData":[],"Salts":[],"Scheduling":[{"gov":"United Kingdom","ref":[],"schedule":"Class B substance"},{"act":"Neue-psychoaktive-Stoffe-Gesetz (NpSG)","gov":"Germany","ref":[],"schedule":"Neuer-Psychoaktiver-Stoff"}],"StereoisomerData":[],"Stereoisomers":[],"Structure":"\u003csvg xmlns=\"http://www.w3.org/2000/svg\" preserveAspectRatio=\"none\" style=\"display:block\" viewBox=\"0 0 52.184 96.244\"\u003e\u003crect width=\"100%\" height=\"100%\" fill=\"#fff\"/\u003e\u003cdesc\u003eGenerated by the Chemistry Development Kit (http://github.com/cdk)\u003c/desc\u003e\u003cg fill=\"#3050f8\" stroke=\"#000\" stroke-linecap=\"round\" stroke-linejoin=\"round\" stroke-width=\".7\"\u003e\u003cpath fill=\"#fff\" stroke=\"none\" d=\"M0 0h53v97H0z\"/\u003e\u003cg class=\"mol\"\u003e\u003cpath d=\"m49.958 27.037-9.795 11.676M40.163 38.713l3.843 10.555M42.537 56.419l-6.955 8.29M35.582 64.709l13.199 7.62M48.781 72.329l-.005 15.248M48.776 87.577l-13.203 7.629M35.573 95.206l-13.199-7.62M22.374 87.586l.005-15.249M35.582 64.709l-13.203 7.628M35.582 64.709l-9.798-11.673\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m25.784 53.036 5.207-14.323M23.973 50.88l4.245-11.676\"/\u003e\u003c/g\u003e\u003cpath d=\"m30.991 38.713-9.81-11.674\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M21.181 27.039 6.26 29.723M20.223 29.689 8.072 31.874\"/\u003e\u003c/g\u003e\u003cpath d=\"M6.26 29.723 1.053 44.045\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m1.053 44.045 9.714 11.64M3.824 43.56l7.91 9.478\"/\u003e\u003c/g\u003e\u003cpath d=\"m25.784 53.036-15.017 2.649M21.181 27.039l3.825-10.574M23.81 9.676l-7.266-8.623\" class=\"bond\"/\u003e\u003cg stroke=\"none\" class=\"atom\"\u003e\u003cpath d=\"M47.318 55.483h-.72l-2.62-4.066h-.029l.029.595q.024.357.024.732v2.739h-.565v-4.9h.714l2.607 4.055h.03l-.018-.328-.024-.476q-.005-.262-.005-.482v-2.769h.577zM51.624 55.483h-.619v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.619z\"/\u003e\u003c/g\u003e\u003cpath fill=\"#ff0d0d\" stroke=\"none\" d=\"M28.624 12.705q0 .756-.256 1.327-.256.566-.757.881-.5.316-1.244.316-.756 0-1.262-.316-.506-.315-.756-.887-.244-.571-.244-1.333 0-.75.244-1.31.25-.565.756-.881.506-.315 1.274-.315.732 0 1.232.315.501.31.757.875.256.566.256 1.328m-3.864 0q0 .922.387 1.458.393.53 1.22.53.84 0 1.221-.53.387-.536.387-1.458 0-.929-.387-1.453-.381-.524-1.209-.524-.833 0-1.226.524t-.393 1.453\" class=\"atom\"/\u003e\u003cpath stroke=\"#3050f8\" d=\"m44.006 49.268-1.922-5.278M42.537 56.419l-3.478 4.145\" class=\"hi\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"m25.006 16.465-1.913 5.287M23.81 9.676l-3.633-4.312\" class=\"hi\"/\u003e\u003c/g\u003e\u003c/g\u003e\u003c/svg\u003e","Title":"3-Methoxyeticyclidine","UNII":"PX6CYK9I4H","Wikidata":"Q20707021","Wikipedia":"3-MeO-PCE","XLogP":3.2}